The company intends to use the funds to support field validation and the initial production of its BioTOF™ z200, a first-of-its-kind, comprehensive biothreat solution for critical infrastructure.
Led by Michael McLoughlin, Executive Chairman, BioFlyte is a biodefense and microbial identification company that is commercializing a new class of fieldable biological contamination sampling, detection, and identification solutions. The firm’s current application focus is critical infrastructure protection and pandemic response.The BioTOF z200 is a miniaturized, low-cost, and low-power bio-aerosol detection system for continuous and autonomous operation in critical infrastructure environments such as third-party command control systems and architectures. The system consists of a wall mount sensor capable of the autonomous detection and identification of airborne microbes and toxins in real-time. It incorporates matrix-assisted laser desorption and ionization (MALDI) mass spectrometry to acquire a mass spectrum from each collected aerosol sample. The BioTOF offers high sensitivity at 100 threat particles per liter of ambient air.
19/04/2022
